SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Mar. 22, 2023-- Quince Therapeutics, Inc. (Nasdaq: QNCX), a biotechnology company focused on acquiring, developing, and commercializing innovative therapeutics that transform patients’ lives, today confirmed that it received an unsolicited offer to
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Jan. 30, 2023-- Quince Therapeutics, Inc. (Nasdaq: QNCX), a biotechnology company focused on acquiring, developing, and commercializing innovative therapeutics that transform patients’ lives, today provided an update on the company’s development
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Jan. 27, 2023-- Quince Therapeutics, Inc. (Nasdaq: QNCX), a biopharmaceutical company advancing innovative precision therapeutics targeting debilitating and rare diseases, announced the sale of the company’s legacy small molecule protease inhibitor